CION Ameerpet
A TP53 mutation raises your lifetime cancer risk, but knowledge is power. We help you plan MRI surveillance and coordinate care, so any tumour is caught early. You deserve a team that walks this journey with you.
Learning that a gene fault runs in your family is frightening. If you or a relative carries a change in the TP53 gene, you may have heard the words Li-Fraumeni syndrome (LFS) — and read some alarming things online. This page is here to give you calm, clear facts: what the risk actually is, when genetic testing helps, how brain tumour surveillance works, and how CION coordinates your care.
The most important message first: carrying a TP53 mutation is not a diagnosis of cancer. It means your lifetime risk is higher, and that a planned, MRI-based monitoring schedule gives the best chance of catching any tumour early — when treatment is simpler. Knowledge here truly is protective. For the bigger picture on inherited risk, see our guide on whether brain tumours are hereditary.
TP53 is often called "the guardian of the genome" because it helps repair damaged DNA and stops faulty cells from dividing. According to the US National Cancer Institute, an inherited fault in TP53 causes Li-Fraumeni syndrome, which raises the lifetime risk of several cancers — including brain tumours, sarcomas, early breast cancer and adrenal tumours. But risk is not certainty: many carriers never develop a brain tumour, and structured screening is designed to catch problems early.
Li-Fraumeni syndrome is a rare inherited condition caused by a change (mutation) in the TP53 gene, which you can pass on to children. Because TP53 normally protects cells from turning cancerous, a fault in it raises the chance that cancers develop — often at younger ages than usual, and sometimes more than one over a lifetime.
LFS is linked to a "core" group of cancers. Brain tumours are one of them, alongside:
Not everyone with a TP53 mutation develops these cancers, and the pattern differs between families and between specific variants. That is exactly why a personalised plan — built with a genetic counsellor and an oncology team — matters more than a single statistic.
In Li-Fraumeni syndrome, certain brain tumour types appear more often. Knowing which ones helps your team plan the right imaging and, if needed, the right molecular testing on any biopsy.
Tumours arising from the brain's glial support cells. In LFS these can include higher-grade astrocytomas and, less commonly, glioblastoma. Molecular testing (such as IDH status) on any biopsy helps confirm the exact subtype and guide treatment. Our brain tumour treatment page explains the modern approach in detail.
A rare tumour of the tissue that makes cerebrospinal fluid. It is strongly associated with LFS in young children — so much so that its diagnosis can prompt TP53 testing for the whole family. Early detection through surveillance makes a meaningful difference.
These childhood tumours can occur in LFS. Because they are primarily paediatric, care for children is managed under CION's pediatric cancer pathway, with the same molecular-testing rigour and family-centred support.
We're never more than 30 minutes away. Same panel of specialists at every centre. Same tumour board reviews. Same NCCN protocols. Pick the closest one and call directly — or let us pick for you.
CION Ameerpet
CION Kukatpally
CION L.B. Nagar
CION Tolichowki
CION Masab Tank
CION Banjara Hills
CION Kompally
CION Balanagar
CION Siddipet
CION Sangareddy
Not sure which centre fits best? Tell us where you are — we'll suggest the closest one with the right specialists.
Help me pick the right centreTravelling for treatment? We may have a centre right where you are.
Don't see your city? Call 18002028726 — we'll find your nearest CION partner centre.
Trained at AIIMS, Tata Memorial, and leading international centres. Combined 150+ years of experience. Every complex case is reviewed by 3+ of them — together.
MBBS(Gold Medal), DNB(General Medicine), DM(Medical Oncology)(Gold Medal)
MBBS, MD(General Medicine), DM(Medical Oncology)(Adyar,Chennai), ECMO, MRCP SCE(UK)
MBBS, MD (General Medicine), DrNB (Medical Oncology), ECMO, MRCP SCE (Medical Oncology) (UK)
MBBS (AIIMS), MS (Surgery) (AIIMS), DNB (Surgical Oncology), MRCS (Edinburgh)
MBBS, MS(General Surgery), M.Ch(Surgical Oncology), FMAS, FARIS(Ongoing)
MBBS, MS (General Surgery), DrNB (Surgical Oncology), FALS Oncology
Want a specific doctor for your case? Mention them when booking.
Book Free ConsultationShare your name and number — we'll call you back within 30 minutes to schedule your consultation.
Whether you carry a known TP53 variant or have a strong family history of brain tumours, sarcoma or early breast cancer, our team will help you understand your risk and build a monitoring plan — for you and your family.
Genetic testing is a personal decision, and it always starts with a conversation — not a blood test. A genetic counsellor reviews your personal and family history, explains what a result would mean for you and your relatives, and only then, if you choose, arranges the test. It is worth discussing testing when there is a strong pattern of the LFS-linked cancers, for example:
A positive result opens the door to a structured surveillance plan that can save lives. A negative result can bring genuine reassurance. Either way, you stay in control of the decision. CION coordinates genetic counselling and TP53 testing with accredited partners and reviews every result with our team.
Ready to talk it through? Book a free consultation or call 18002028726 — we'll explain your options with no pressure.
For people with a confirmed TP53 mutation, expert bodies recommend lifelong surveillance to detect any tumour at its earliest, most treatable stage. Well-known protocols — such as the widely adopted "Toronto protocol" — combine clinical review with regular imaging. For the brain, this usually means a brain MRI, most often once a year, as part of a whole-body screening plan that also covers the breasts, abdomen and other sites.
Why MRI and not CT? Because MRI does not use ionising radiation. This matters a great deal in Li-Fraumeni syndrome, where cells are more sensitive to radiation-induced damage. Choosing MRI-based surveillance avoids adding radiation exposure year after year.
CION helps arrange and coordinate this imaging alongside your genetics team. Because a brain tumour headache is rarely the first sign in surveillance, the whole point is to find changes on a scan before red-flag symptoms — a new, persistent and progressive headache, a first-ever adult seizure, one-sided weakness or speech loss, or sudden vision change — ever develop. If any of those symptoms do appear, they need urgent assessment.
Because TP53 normally protects cells from DNA damage, people with LFS can be more prone to radiation-induced second cancers. This does not mean radiation is off the table — it remains an important, sometimes essential, treatment for many brain tumours. It does mean the team weighs its use especially carefully and looks for equally effective options that spare radiation where they exist.
This principle shapes care in two ways. First, in surveillance, MRI replaces CT wherever possible. Second, in treatment, any radiation plan for a person with a known TP53 mutation is discussed by a multidisciplinary tumour board, so the benefits and the long-term risks are balanced for that individual. At CION we deliver radiation therapy (such as IMRT and IGRT) and systemic treatment directly; any neurosurgery is coordinated with accredited neurosurgical partners. Guideline frameworks from NCCN and EANO inform every plan.
Surveillance works. Published studies of TP53 carriers following whole-body and brain MRI screening protocols (the "Toronto protocol") have reported that tumours detected during surveillance tend to be found at an earlier, more treatable stage than those found only after symptoms appear. This is the core reason experts recommend structured MRI monitoring rather than waiting for warning signs.
Li-Fraumeni syndrome does not affect one person in isolation — it affects parents, children and siblings across generations. CION is built to walk that journey with your whole family:
We make decisions for healing, not billing, with transparent costs from the start. Explore the full picture on our brain cancer and tumour hub, or read about brain tumour treatment in Hyderabad.
Get a free second opinion from CION's tumour board — especially valuable if genetic testing or MRI surveillance has not yet been discussed with you.
These aren't paid endorsements or written reviews. These are video testimonials from real patients and families — recorded on their own phones, in their own words. Pick any one. Watch it. Then decide.
Read all 800+ reviews on Google
Start Your Story. Book Free Consultation.No. Li-Fraumeni syndrome (LFS) raises the lifetime risk of several cancers, but it does not mean a brain tumour will happen. Brain tumours are one of the "core" LFS cancers, alongside breast cancer, soft-tissue and bone sarcomas, and adrenal tumours. Many people who carry a TP53 mutation never develop a brain tumour at all. Risk varies with the specific variant, family history and age. What LFS does mean is that screening matters — early detection through planned MRI surveillance gives the best chance of catching any tumour when it is small and most treatable. If you carry a TP53 variant, the goal is watchful, structured monitoring, not fear.
The brain tumours most often seen in Li-Fraumeni syndrome are gliomas (including higher-grade astrocytomas and glioblastoma) and choroid plexus carcinoma, which is especially associated with LFS in young children. Medulloblastoma and other embryonal tumours can also occur. Because the TP53 gene normally helps repair DNA and stop faulty cells from dividing, a inherited fault raises the chance these cells grow unchecked. The exact type still needs an MRI and, where appropriate, a biopsy with molecular testing to confirm. You can read more about how tumours form on our brain tumour hub.
Genetic testing is worth discussing if you have a strong personal or family history of the LFS-linked cancers — for example, a childhood brain tumour, sarcoma, early breast cancer, or adrenal tumour, or several close relatives with these cancers at young ages. Testing is done through a genetic counsellor, who explains what a result means for you and your family before any blood test. A positive TP53 result opens the door to a structured surveillance plan. A negative result can bring reassurance. CION coordinates genetic counselling and testing with accredited partners — the decision is always yours, made with full information.
For people with a confirmed TP53 mutation, expert protocols such as the "Toronto protocol" recommend a whole-body and brain MRI, usually every year, as part of lifelong surveillance. Brain MRI is preferred because it avoids the radiation of CT scans — an important point in LFS, where cells are more sensitive to radiation-induced damage. Surveillance also covers breast, abdomen and other sites. The aim is to find any tumour early, when treatment is simpler and outcomes are better. CION helps arrange and coordinate this MRI-based monitoring alongside your genetics team, so nothing falls through the gaps.
Because TP53 normally protects cells from DNA damage, people with LFS can be more prone to radiation-induced second cancers. Radiation is not banned — it is still an important treatment for many brain tumours — but the team weighs its use carefully and prefers non-radiation options where they work just as well. This is exactly why surveillance uses MRI rather than repeated CT scans. At CION, radiation planning for anyone with a known TP53 mutation is discussed in a multidisciplinary tumour board, so the benefits and long-term risks are balanced for you specifically.
CION brings together medical oncology, radiation oncology, imaging and molecular testing, and coordinates genetic counselling and any neurosurgery with accredited partner teams. Every patient with a suspected or confirmed TP53 mutation is reviewed by our tumour board. We help set up the MRI surveillance schedule, explain results in plain language, and stay with families across generations — because LFS affects parents, children and siblings. Our 45-minute consultation gives time for the questions that a rushed appointment cannot. We make decisions for healing, not billing, and walk this journey with you.
Browse our complete guide to brain tumours and brain cancer — symptoms, scans, tumour types, treatment, prognosis and life after treatment. Tap any topic to read more.